Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fumiko Inoue

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Enhancement of sensitivity to tumor necrosis factor alpha in non-small cell lung cancer cells with acquired resistance to gefitinibKoichi Ando, Tohru Ohmori, Fumiko Inoue, et al.
Anticancer Research|June 17, 2009
Combination effect between bortezomib and tumor necrosis factor alpha on gefitinib-resistant non-small cell lung cancer cell linesSojiro Kusumoto, Tomohide Sugiyama, Koichi Ando, et al.
Anticancer Research|August 19, 2007
Mutant epidermal growth factor receptor undergoes less protein degradation due to diminished binding to c-CblTakamichi Hosaka, Fumiko Inoue, Koichi Ando, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2005
Enhancement of sensitivity to tumor necrosis factor alpha in non-small cell lung cancer cells with acquired resistance to gefitinibKoichi Ando, Tohru Ohmori, Fumiko Inoue, et al.
Anticancer Research|June 17, 2009
Combination effect between bortezomib and tumor necrosis factor alpha on gefitinib-resistant non-small cell lung cancer cell linesSojiro Kusumoto, Tomohide Sugiyama, Koichi Ando, et al.
Anticancer Research|August 19, 2007
Mutant epidermal growth factor receptor undergoes less protein degradation due to diminished binding to c-CblTakamichi Hosaka, Fumiko Inoue, Koichi Ando, et al.
Pageof 2